바이러스 제거 서비스 : 세계 시장 점유율과 순위, 총판매량 및 수요 예측(2025-2031년)

The global market for Viral Clearance Service was estimated to be worth US$ 572 million in 2024 and is forecast to a readjusted size of US$ 1667 million by 2031 with a CAGR of 16.5% during the forecast period 2025-2031.

Viral clearance services refer to viral removal or viral inactivation service. Viral clearance studies are a critical element toward ensuring that an acceptable level of viral safety has been achieved for biological products. The goal of these studies is to demonstrate that the manufacturing purification process has the ability to inactivate and/or remove viruses that are known to contaminate or which may possibly contaminate the starting materials, as well as additional viruses that are models for a broad variety of viruses. Viral clearance studies provide a complementary strategy to direct testing of cell banks, raw materials and bioreactor harvests, which may not detect all viruses that could potentially contaminate the product.

The viral clearance service market is primarily driven by the rapid growth of the global biopharmaceutical industry and increasingly stringent regulatory requirements for product safety and compliance. With the widespread adoption of biologics such as monoclonal antibodies, recombinant proteins, cell therapies, and gene therapies, the risk of viral contamination during production has become a critical concern for regulatory agencies, fueling demand for robust viral clearance validation services. Biopharmaceutical companies seeking clinical trial approval or product commercialization are required to submit comprehensive viral clearance data to meet the stringent standards of regulatory bodies like the FDA, EMA, and others, making these services essential to product development pipelines. Additionally, the rise of CDMOs (Contract Development and Manufacturing Organizations) and CROs (Contract Research Organizations) has accelerated the outsourcing of viral clearance testing, allowing companies to improve development efficiency and ensure regulatory compliance. As the global biopharma supply chain becomes more integrated and technological advancements continue to enhance the sensitivity and reliability of viral detection and removal methods, the viral clearance service market is expected to maintain strong and sustained growth.

North America is the largest Viral Clearance Service market with about 51% market share. Europe is follower, accounting for about 23% market share.The key manufacturers are Charles River, BioReliance (Merck), Eurofins Scientific, Sartorius, Covance, ViruSure, Texcell, Bioscience Labs, Vironova Biosafety, Merieux NutriSciences, WuXi AppTec, Syngene, Labor Dr. Merk etc. Top 3 companies occupied about 39% market share.

This report aims to provide a comprehensive presentation of the global market for Viral Clearance Service, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Viral Clearance Service by region & country, by Application, and by End User.

The Viral Clearance Service market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Viral Clearance Service.

Market Segmentation

By Company

• Charles River
• Sigma-Aldrich (Merck)
• Eurofins Scientific
• Sartorius
• Labcorp
• ViruSure
• Texcell
• Bioscience Labs
• QuTEM
• Merieux NutriSciences
• WuXi AppTec
• Syngene
• Boehringer Ingelheim
• Sino Biological
• Creative Biogene

Segment by Application

• For Pharmaceuticals
• For Biopharmaceuticals
• For Medical Devices

Segment by End User

• Research Institution
• Pharmaceutical Industry
• Others

By Region

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia-Pacific
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Netherlands
  • Nordic Countries
  • Rest of Europe
• Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Viral Clearance Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by End User, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Viral Clearance Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Viral Clearance Service in country level. It provides sigmate data by Application, and by End User for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

• 1.1 Viral Clearance Service Product Introduction
• 1.2 Global Viral Clearance Service Market Size Forecast (2020-2031)
• 1.3 Viral Clearance Service Market Trends & Drivers
  • 1.3.1 Viral Clearance Service Industry Trends
  • 1.3.2 Viral Clearance Service Market Drivers & Opportunity
  • 1.3.3 Viral Clearance Service Market Challenges
  • 1.3.4 Viral Clearance Service Market Restraints
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Competitive Analysis by Company

• 2.1 Global Viral Clearance Service Players Revenue Ranking (2024)
• 2.2 Global Viral Clearance Service Revenue by Company (2020-2025)
• 2.3 Key Companies Viral Clearance Service Manufacturing Base Distribution and Headquarters
• 2.4 Key Companies Viral Clearance Service Product Offered
• 2.5 Key Companies Time to Begin Mass Production of Viral Clearance Service
• 2.6 Viral Clearance Service Market Competitive Analysis
  • 2.6.1 Viral Clearance Service Market Concentration Rate (2020-2025)
  • 2.6.2 Global 5 and 10 Largest Companies by Viral Clearance Service Revenue in 2024
  • 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Clearance Service as of 2024)
• 2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Application

• 3.1 Introduction by Application
  • 3.1.1 For Pharmaceuticals
  • 3.1.2 For Biopharmaceuticals
  • 3.1.3 For Medical Devices
• 3.2 Global Viral Clearance Service Sales Value by Application
  • 3.2.1 Global Viral Clearance Service Sales Value by Application (2020 VS 2024 VS 2031)
  • 3.2.2 Global Viral Clearance Service Sales Value, by Application (2020-2031)
  • 3.2.3 Global Viral Clearance Service Sales Value, by Application (%) (2020-2031)

4 Segmentation by End User

• 4.1 Introduction by End User
  • 4.1.1 Research Institution
  • 4.1.2 Pharmaceutical Industry
  • 4.1.3 Others
• 4.2 Global Viral Clearance Service Sales Value by End User
  • 4.2.1 Global Viral Clearance Service Sales Value by End User (2020 VS 2024 VS 2031)
  • 4.2.2 Global Viral Clearance Service Sales Value, by End User (2020-2031)
  • 4.2.3 Global Viral Clearance Service Sales Value, by End User (%) (2020-2031)

5 Segmentation by Region

• 5.1 Global Viral Clearance Service Sales Value by Region
  • 5.1.1 Global Viral Clearance Service Sales Value by Region: 2020 VS 2024 VS 2031
  • 5.1.2 Global Viral Clearance Service Sales Value by Region (2020-2025)
  • 5.1.3 Global Viral Clearance Service Sales Value by Region (2026-2031)
  • 5.1.4 Global Viral Clearance Service Sales Value by Region (%), (2020-2031)
• 5.2 North America
  • 5.2.1 North America Viral Clearance Service Sales Value, 2020-2031
  • 5.2.2 North America Viral Clearance Service Sales Value by Country (%), 2024 VS 2031
• 5.3 Europe
  • 5.3.1 Europe Viral Clearance Service Sales Value, 2020-2031
  • 5.3.2 Europe Viral Clearance Service Sales Value by Country (%), 2024 VS 2031
• 5.4 Asia Pacific
  • 5.4.1 Asia Pacific Viral Clearance Service Sales Value, 2020-2031
  • 5.4.2 Asia Pacific Viral Clearance Service Sales Value by Region (%), 2024 VS 2031
• 5.5 South America
  • 5.5.1 South America Viral Clearance Service Sales Value, 2020-2031
  • 5.5.2 South America Viral Clearance Service Sales Value by Country (%), 2024 VS 2031
• 5.6 Middle East & Africa
  • 5.6.1 Middle East & Africa Viral Clearance Service Sales Value, 2020-2031
  • 5.6.2 Middle East & Africa Viral Clearance Service Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

• 6.1 Key Countries/Regions Viral Clearance Service Sales Value Growth Trends, 2020 VS 2024 VS 2031
• 6.2 Key Countries/Regions Viral Clearance Service Sales Value, 2020-2031
• 6.3 United States
  • 6.3.1 United States Viral Clearance Service Sales Value, 2020-2031
  • 6.3.2 United States Viral Clearance Service Sales Value by Application (%), 2024 VS 2031
  • 6.3.3 United States Viral Clearance Service Sales Value by End User, 2024 VS 2031
• 6.4 Europe
  • 6.4.1 Europe Viral Clearance Service Sales Value, 2020-2031
  • 6.4.2 Europe Viral Clearance Service Sales Value by Application (%), 2024 VS 2031
  • 6.4.3 Europe Viral Clearance Service Sales Value by End User, 2024 VS 2031
• 6.5 China
  • 6.5.1 China Viral Clearance Service Sales Value, 2020-2031
  • 6.5.2 China Viral Clearance Service Sales Value by Application (%), 2024 VS 2031
  • 6.5.3 China Viral Clearance Service Sales Value by End User, 2024 VS 2031
• 6.6 Japan
  • 6.6.1 Japan Viral Clearance Service Sales Value, 2020-2031
  • 6.6.2 Japan Viral Clearance Service Sales Value by Application (%), 2024 VS 2031
  • 6.6.3 Japan Viral Clearance Service Sales Value by End User, 2024 VS 2031
• 6.7 South Korea
  • 6.7.1 South Korea Viral Clearance Service Sales Value, 2020-2031
  • 6.7.2 South Korea Viral Clearance Service Sales Value by Application (%), 2024 VS 2031
  • 6.7.3 South Korea Viral Clearance Service Sales Value by End User, 2024 VS 2031
• 6.8 Southeast Asia
  • 6.8.1 Southeast Asia Viral Clearance Service Sales Value, 2020-2031
  • 6.8.2 Southeast Asia Viral Clearance Service Sales Value by Application (%), 2024 VS 2031
  • 6.8.3 Southeast Asia Viral Clearance Service Sales Value by End User, 2024 VS 2031
• 6.9 India
  • 6.9.1 India Viral Clearance Service Sales Value, 2020-2031
  • 6.9.2 India Viral Clearance Service Sales Value by Application (%), 2024 VS 2031
  • 6.9.3 India Viral Clearance Service Sales Value by End User, 2024 VS 2031

7 Company Profiles

• 7.1 Charles River
  • 7.1.1 Charles River Profile
  • 7.1.2 Charles River Main Business
  • 7.1.3 Charles River Viral Clearance Service Products, Services and Solutions
  • 7.1.4 Charles River Viral Clearance Service Revenue (US$ Million) & (2020-2025)
  • 7.1.5 Charles River Recent Developments
• 7.2 Sigma-Aldrich (Merck)
  • 7.2.1 Sigma-Aldrich (Merck) Profile
  • 7.2.2 Sigma-Aldrich (Merck) Main Business
  • 7.2.3 Sigma-Aldrich (Merck) Viral Clearance Service Products, Services and Solutions
  • 7.2.4 Sigma-Aldrich (Merck) Viral Clearance Service Revenue (US$ Million) & (2020-2025)
  • 7.2.5 Sigma-Aldrich (Merck) Recent Developments
• 7.3 Eurofins Scientific
  • 7.3.1 Eurofins Scientific Profile
  • 7.3.2 Eurofins Scientific Main Business
  • 7.3.3 Eurofins Scientific Viral Clearance Service Products, Services and Solutions
  • 7.3.4 Eurofins Scientific Viral Clearance Service Revenue (US$ Million) & (2020-2025)
  • 7.3.5 Eurofins Scientific Recent Developments
• 7.4 Sartorius
  • 7.4.1 Sartorius Profile
  • 7.4.2 Sartorius Main Business
  • 7.4.3 Sartorius Viral Clearance Service Products, Services and Solutions
  • 7.4.4 Sartorius Viral Clearance Service Revenue (US$ Million) & (2020-2025)
  • 7.4.5 Sartorius Recent Developments
• 7.5 Labcorp
  • 7.5.1 Labcorp Profile
  • 7.5.2 Labcorp Main Business
  • 7.5.3 Labcorp Viral Clearance Service Products, Services and Solutions
  • 7.5.4 Labcorp Viral Clearance Service Revenue (US$ Million) & (2020-2025)
  • 7.5.5 Labcorp Recent Developments
• 7.6 ViruSure
  • 7.6.1 ViruSure Profile
  • 7.6.2 ViruSure Main Business
  • 7.6.3 ViruSure Viral Clearance Service Products, Services and Solutions
  • 7.6.4 ViruSure Viral Clearance Service Revenue (US$ Million) & (2020-2025)
  • 7.6.5 ViruSure Recent Developments
• 7.7 Texcell
  • 7.7.1 Texcell Profile
  • 7.7.2 Texcell Main Business
  • 7.7.3 Texcell Viral Clearance Service Products, Services and Solutions
  • 7.7.4 Texcell Viral Clearance Service Revenue (US$ Million) & (2020-2025)
  • 7.7.5 Texcell Recent Developments
• 7.8 Bioscience Labs
  • 7.8.1 Bioscience Labs Profile
  • 7.8.2 Bioscience Labs Main Business
  • 7.8.3 Bioscience Labs Viral Clearance Service Products, Services and Solutions
  • 7.8.4 Bioscience Labs Viral Clearance Service Revenue (US$ Million) & (2020-2025)
  • 7.8.5 Bioscience Labs Recent Developments
• 7.9 QuTEM
  • 7.9.1 QuTEM Profile
  • 7.9.2 QuTEM Main Business
  • 7.9.3 QuTEM Viral Clearance Service Products, Services and Solutions
  • 7.9.4 QuTEM Viral Clearance Service Revenue (US$ Million) & (2020-2025)
  • 7.9.5 QuTEM Recent Developments
• 7.10 Merieux NutriSciences
  • 7.10.1 Merieux NutriSciences Profile
  • 7.10.2 Merieux NutriSciences Main Business
  • 7.10.3 Merieux NutriSciences Viral Clearance Service Products, Services and Solutions
  • 7.10.4 Merieux NutriSciences Viral Clearance Service Revenue (US$ Million) & (2020-2025)
  • 7.10.5 Merieux NutriSciences Recent Developments
• 7.11 WuXi AppTec
  • 7.11.1 WuXi AppTec Profile
  • 7.11.2 WuXi AppTec Main Business
  • 7.11.3 WuXi AppTec Viral Clearance Service Products, Services and Solutions
  • 7.11.4 WuXi AppTec Viral Clearance Service Revenue (US$ Million) & (2020-2025)
  • 7.11.5 WuXi AppTec Recent Developments
• 7.12 Syngene
  • 7.12.1 Syngene Profile
  • 7.12.2 Syngene Main Business
  • 7.12.3 Syngene Viral Clearance Service Products, Services and Solutions
  • 7.12.4 Syngene Viral Clearance Service Revenue (US$ Million) & (2020-2025)
  • 7.12.5 Syngene Recent Developments
• 7.13 Boehringer Ingelheim
  • 7.13.1 Boehringer Ingelheim Profile
  • 7.13.2 Boehringer Ingelheim Main Business
  • 7.13.3 Boehringer Ingelheim Viral Clearance Service Products, Services and Solutions
  • 7.13.4 Boehringer Ingelheim Viral Clearance Service Revenue (US$ Million) & (2020-2025)
  • 7.13.5 Boehringer Ingelheim Recent Developments
• 7.14 Sino Biological
  • 7.14.1 Sino Biological Profile
  • 7.14.2 Sino Biological Main Business
  • 7.14.3 Sino Biological Viral Clearance Service Products, Services and Solutions
  • 7.14.4 Sino Biological Viral Clearance Service Revenue (US$ Million) & (2020-2025)
  • 7.14.5 Sino Biological Recent Developments
• 7.15 Creative Biogene
  • 7.15.1 Creative Biogene Profile
  • 7.15.2 Creative Biogene Main Business
  • 7.15.3 Creative Biogene Viral Clearance Service Products, Services and Solutions
  • 7.15.4 Creative Biogene Viral Clearance Service Revenue (US$ Million) & (2020-2025)
  • 7.15.5 Creative Biogene Recent Developments

8 Industry Chain Analysis

• 8.1 Viral Clearance Service Industrial Chain
• 8.2 Viral Clearance Service Upstream Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
  • 8.2.3 Manufacturing Cost Structure
• 8.3 Midstream Analysis
• 8.4 Downstream Analysis (Customers Analysis)
• 8.5 Sales Model and Sales Channels
  • 8.5.1 Viral Clearance Service Sales Model
  • 8.5.2 Sales Channel
  • 8.5.3 Viral Clearance Service Distributors

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
    • 10.1.1.1 Research Programs/Design
    • 10.1.1.2 Market Size Estimation
    • 10.1.1.3 Market Breakdown and Data Triangulation
  • 10.1.2 Data Source
    • 10.1.2.1 Secondary Sources
    • 10.1.2.2 Primary Sources
• 10.2 Author Details
• 10.3 Disclaimer